If your doctor has recently prescribed a GLP-1 injection — or you're considering one — you probably have questions beyond "will it work?". How exactly does it change what happens in your body? What does the injection itself feel like? Where do you inject? How do you not mess it up?
If your doctor has recently prescribed a GLP-1 injection — or you're considering one — you probably have questions beyond "will it work?". How exactly does it change what happens in your body? What does the injection itself feel like? Where do you inject? How do you not mess it up?
This guide answers all of those questions, starting with the biology and ending with a practical walkthrough you can use at home.
GLP-1 stands for glucagon-like peptide-1 — a hormone your gut naturally produces within minutes of eating a meal. Your small intestine releases it in response to incoming food, and it sends a cascade of signals throughout your body.
Here's what those signals do:
In the pancreas: GLP-1 stimulates the beta cells to release insulin in proportion to the glucose arriving from your meal. It also suppresses glucagon — the hormone that raises blood sugar when you haven't eaten — which helps keep post-meal glucose stable. This is called a glucose-dependent mechanism, which is why GLP-1 medications carry a very low risk of hypoglycaemia in people without diabetes.
In the stomach: GLP-1 slows gastric emptying. Food leaves your stomach more slowly and moves through the digestive tract at a reduced pace. The result: you feel full for longer after eating, and the glucose from your meal enters your bloodstream more gradually.
In the brain: GLP-1 receptors are expressed in the hypothalamus — the brain's control centre for hunger, satiety, and reward. Activating these receptors reduces appetite, lowers the perceived reward value of food, and increases the sense of fullness (Drucker DJ, Cell Metab 2018;27:740–756; Blundell J et al., Diabetes Obes Metab 2017;19:1242–1251). Patients commonly report that their relationship with food feels fundamentally different on treatment — cravings diminish, and smaller portions feel genuinely satisfying.
Naturally, GLP-1 has a problem: your body degrades it within 1–2 minutes. The hormone is rapidly broken down by an enzyme called dipeptidyl peptidase-4 (DPP-4), which means its natural effect is brief. GLP-1 receptor agonist medications are engineered to be resistant to this degradation — their half-lives range from hours (liraglutide) to days (semaglutide), enabling once-daily or once-weekly dosing.
The most widely prescribed GLP-1 medication for weight management is semaglutide, available in Singapore as a prescription-only medicine. The key clinical evidence comes from the STEP 1 trial (Wilding et al., N Engl J Med 2021;384:989–1002) — a randomised, double-blind study in 1,961 adults with obesity or overweight with at least one weight-related condition. Over 68 weeks, participants on semaglutide 2.4 mg achieved a mean body weight reduction of 14.9% (approximately 15.3 kg), compared to 2.4% in the placebo group. More than 50% of participants lost ≥15% of body weight — a level of weight loss previously associated only with bariatric surgery.
Semaglutide is administered as a once-weekly subcutaneous injection. It is not an insulin injection. It is not chemotherapy. It is a small-volume injection using an ultra-fine needle into fatty tissue — and for most patients, the fear of injecting outweighs the reality.
Before your first injection, your prescribing doctor or clinical team should walk you through the process. The steps below reflect general best practice and are not a substitute for individual medical guidance.
1. Prepare your supplies
You'll need:
Check the pen: confirm the medication is clear and colourless (not cloudy, discoloured, or containing particles). Check the expiry date. For semaglutide, the pen is pre-filled — you do not need to mix or draw up medication.
2. Choose your injection site
The three approved subcutaneous injection sites are:
Rotate sites each week — avoid injecting into the same spot repeatedly, as this can cause lipodystrophy (hardened fatty tissue under the skin). Many patients keep a simple log or rotate clockwise around their abdomen.
3. Clean and prepare the site
Wipe the chosen site with an alcohol swab. Let it air-dry for a few seconds — injecting through wet skin can sting slightly. Do not rub the area after cleaning.
4. Administer the injection
With most auto-injector pens:
Do not recap the needle. Dispose of it in your sharps container immediately.
5. After the injection
You can gently press a clean swab against the site if there is minor bleeding, but do not rub. You may experience mild redness, minor itching, or a small bruise at the injection site — these are common and typically resolve within 24–48 hours.
The injection itself is usually not painful. The needle is very fine (typically 32 gauge) and very short. Most patients describe it as a slight pressure or nothing at all. If you experience significant pain, the needle may have hit a blood vessel — withdraw, apply pressure, and choose a different site next time.
GLP-1 medications use a dose escalation schedule — you begin at a low dose and increase gradually over several weeks. This is not because the lower dose is therapeutic; it's a strategy to minimise gastrointestinal side effects (nausea, vomiting) while your body adjusts.
For semaglutide 2.4 mg (the weight management dose), a typical escalation schedule runs over 16 weeks:
Do not skip ahead in the escalation schedule without your doctor's advice, even if you feel you're tolerating the medication well. The escalation exists for physiological reasons, not just as a precaution.
Week 1–2: You may notice reduced appetite sooner than you expect. Some patients report nausea, particularly in the day or two after injection. Eat small, low-fat meals. Avoid rich or fried food, which is harder to digest with slowed gastric emptying.
Week 3–8: The dose escalation continues. Nausea typically peaks and then subsides as your body adapts. Most patients see meaningful weight reduction beginning in this window. Fatigue or mild digestive disruption (constipation or loose stools) is common early on.
Week 8 onwards: For most patients, side effects have settled significantly by this point. Appetite suppression is sustained. Weight loss continues. Many patients report that their relationship with food — particularly cravings and emotional eating — has changed noticeably.
Keep all follow-up appointments with your prescribing doctor. Blood pressure, pulse, and relevant labs may be monitored, and your dose will be adjusted on schedule.
Seek medical advice promptly if you experience:
These are rare, but they are documented risks that warrant prompt clinical review.
GLP-1 medications like semaglutide are prescription-only for good reason — they're effective, but they require medical oversight, a proper eligibility assessment, and ongoing monitoring. They are not over-the-counter supplements or lifestyle products.
If you meet the eligibility criteria (typically BMI ≥ 30 kg/m², or ≥ 27 kg/m² with a weight-related condition), a telehealth consultation is the most convenient starting point.
Start your consultation at ofnoah.sg — speak with a licensed doctor, get assessed for eligibility, and if appropriate, begin treatment with full clinical support. No clinic queues. Medication delivered to your door.
This article is for educational purposes only. It does not constitute medical advice. GLP-1 medications are prescription-only medicines in Singapore. Eligibility, dosing, and suitability must be determined by a licensed physician.


Articles featured on Noah are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider.